CR Medical

Company Hospital

China Resources Medical Holdings Reports 2024 Revenue of RMB9.86 Billion Amid Net Profit Surge

Fineline Cube Mar 26, 2025

China Resources Medical Holdings Company Ltd (CR Medical, HKG: 1515) has published its 2024 financial...

Company Deals

Apeloa Partners with MindRank on AI Drug Development Platform

Policy / Regulatory

China Drug Administration Implementation Regulations Set for May 2026 Launch

Company Drug

Henlius Triple Combo Gets NMPA Nod for Advanced Solid Tumor Trials

Company Drug

Hengrui’s HRS-5346 Lp(a) Inhibitor Gets China Breakthrough Therapy Designation in $1.97B Merck Deal